Drug Release Auto-Diagnose

Upload an in vitro release profile. The engine compares 5 release models — First-order, Higuchi, Weibull, Korsmeyer-Peppas and Mittag-Leffler fractional — and returns a 6-rule verdict with regime-B guardrail for incomplete release windows.

Free trial run on your own dataset. The full Pre-PopPK go/no-go report (modules 1-5, PDF + DOCX + JSON) is 499 € per analysis — see pricing. Results are indicative, for research and internal QC, not a regulatory submission. Your dataset is processed in the EU and deleted within 1 hour.
🔒 TLS 1.2+ in transit 🛡 AES-256 at rest ⏱ Auto-deleted within 1 hour 🇪🇺 EU-only (Frankfurt) Privacy policy →

1 · Upload dataset

📂
Click or drag a CSV file
Expected columns: ID · TIME · V (cumulative released fraction in [0,1])
⬇ No data handy? Download an example CSV to try it
▶ Accepted CSV format · click to expand

Required columns (case-insensitive, common aliases accepted):

  • TIME — time since release start. Aliases: time, t, time_min, time_h, min, minutes, hours, tiempo, temps, zeit, minuto, hora
  • V — cumulative released fraction in [0, 1]. Aliases: v, fraction, frac, released, pct_released, percent_released, Q, cumulative_release, liberacion, fraccion_liberada

Optional: ID (formulation identifier — aliases: formulation, batch, batch_id, formulacion, lote).

Header flexibility — punctuation, case, and parenthesised units are tolerated. Time (min), % Released, cum-release all map correctly. ES/FR/DE headers are accepted.

Minimum size: 4 distinct time points. Percent values (0–100) are auto-converted to fractions (0–1).

Example:

ID,TIME,V
A,0,0.00
A,2,0.18
A,4,0.34
A,8,0.55
A,16,0.78
A,24,0.90

Do NOT submit datasets with direct identifiers. Use pseudonymised batch/formulation IDs.

Starting…
You can close this tab — we'll email the report when it's ready.
This report contains computational results. Pharmacological interpretation and clinical decisions are the responsibility of the client's expert team. FractaLPK does not provide medical, pharmacological, or regulatory advice.